Buscar resultados de ensayos clínicos
Lymphohistiocytosis, Hemophagocytic - 25 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Children and Adult Hemophagocytic Syndrome (HLHa) Condición: Hemophagocytic Syndrome Fecha: 2013-05-24 Intervenciones: Biological: Identification of biological markers |
Recruiting |
Nombre del estudio: L-DEP as an Initial Treatment for EBV-HLH Condición: Hemophagocytic Lymphohistiocytosis Fecha: 2016-09-09 Intervenciones:
|
Recruiting |
Nombre del estudio: Trial of DA-EPOCH Regimen for NHL With HLH Condición: NHL With Hemophagocytic Lymphohistiocytosis Fecha: 2013-03-23 Intervenciones: Drug: DA-EPOCH DA-EPOCH regimen Other Names: |
Recruiting |
Nombre del estudio: Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody Condición: Hemophagocytic Lymphohistiocytosis Fecha: 2013-12-23 Intervenciones: Drug: NI-0501 In the event that NI-0501 treatment needs to be prolonged beyond Week 8 foreseen in the pr |
Recruiting |
Nombre del estudio: Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymphohistiocytosis Condición: Nonneoplastic Condition Fecha: 2006-06-07 Intervenciones:
|
Recruiting |
Nombre del estudio: Treatment of Familiar Lymphohistiocytosis Condición: Hemophagocytic Lymphohistiocytosis (HLH) Fecha: 2015-06-08 Intervenciones:
|
Completed |
Nombre del estudio: Secondary Adult's Hemophagocytic Lymphohistiocytosis and Innate Immunity Condición: Hemophagocytic Lymphohisticytosis Fecha: 2010-05-17 Intervenciones: Other: blood sample |
Recruiting |
Nombre del estudio: Alemtuzumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis Condición: Leukemia Fecha: 2015-03-05 Intervenciones:
|
Recruiting |
Nombre del estudio: New Candidate Criteria for Diagnosis of Macrophage Activation Syndrome Condición:
|
Active, not recruiting |
Nombre del estudio: Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) Condición:
|